Financials Zenicor Medical Systems AB

Equities

ZENI

SE0006343984

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET 23:00:00 30/01/2024 GMT 5-day change 1st Jan Change
2.98 SEK -1.32% Intraday chart for Zenicor Medical Systems AB -.--% -6.88%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 115 82.29 69.32 167.4 115.5 28.87
Enterprise Value (EV) 1 111.9 86.39 75.88 177.9 132.8 41.74
P/E ratio -42.5 x -47.9 x 48.6 x 266 x -66.1 x -5.17 x
Yield - - - - - -
Capitalization / Revenue 4.64 x 3.33 x 2.98 x 6.45 x 3.94 x 0.89 x
EV / Revenue 4.51 x 3.49 x 3.26 x 6.86 x 4.53 x 1.29 x
EV / EBITDA -47 x -67.3 x 41.2 x 143 x -184 x -16.5 x
EV / FCF -13 x -13.2 x -25.1 x -42.1 x -21.6 x -3.1 x
FCF Yield -7.71% -7.6% -3.98% -2.38% -4.64% -32.3%
Price to Book 6.49 x 5.15 x 3.98 x 9.27 x 7.09 x 0.94 x
Nbr of stocks (in thousands) 5,636 5,636 5,636 5,636 5,636 9,023
Reference price 2 20.40 14.60 12.30 29.70 20.50 3.200
Announcement Date 29/04/19 24/04/20 27/04/21 03/05/22 20/04/23 22/04/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 24.79 24.74 23.26 25.94 29.31 32.26
EBITDA 1 -2.381 -1.284 1.843 1.243 -0.7216 -2.534
EBIT 1 -2.468 -1.373 1.788 1.214 -0.7653 -4.111
Operating Margin -9.95% -5.55% 7.68% 4.68% -2.61% -12.74%
Earnings before Tax (EBT) 1 -2.704 -1.718 1.426 0.6288 -1.747 -5.588
Net income 1 -2.704 -1.718 1.426 0.6288 -1.747 -5.588
Net margin -10.91% -6.94% 6.13% 2.42% -5.96% -17.32%
EPS 2 -0.4798 -0.3048 0.2529 0.1116 -0.3100 -0.6193
Free Cash Flow 1 -8.626 -6.566 -3.019 -4.228 -6.156 -13.48
FCF margin -34.79% -26.54% -12.98% -16.3% -21.01% -41.78%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 29/04/19 24/04/20 27/04/21 03/05/22 20/04/23 22/04/24
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 4.1 6.56 10.5 17.3 12.9
Net Cash position 1 3.08 - - - - -
Leverage (Debt/EBITDA) - -3.195 x 3.559 x 8.465 x -23.91 x -5.079 x
Free Cash Flow 1 -8.63 -6.57 -3.02 -4.23 -6.16 -13.5
ROE (net income / shareholders' equity) -26.3% -10.2% 8.53% 3.55% -10.2% -23.8%
ROA (Net income/ Total Assets) -8.17% -3.14% 3.62% 2.07% -1.11% -4.84%
Assets 1 33.09 54.73 39.41 30.43 157.7 115.4
Book Value Per Share 2 3.140 2.840 3.090 3.200 2.890 3.390
Cash Flow per Share 2 1.120 0.4800 0.2100 0.1900 0.1000 0.3500
Capex 1 0.04 0.03 0.01 0.06 4.63 0.12
Capex / Sales 0.17% 0.14% 0.05% 0.23% 15.79% 0.36%
Announcement Date 29/04/19 24/04/20 27/04/21 03/05/22 20/04/23 22/04/24
1SEK in Million2SEK
Estimates
  1. Stock Market
  2. Equities
  3. ZENI Stock
  4. Financials Zenicor Medical Systems AB